Yüklüyor......
Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
Identifying disease-modifying therapies for neurological diseases remains one of the greatest gaps in modern medicine. Herein, we present the rationale for intranasal (IN) delivery of deferoxamine (DFO), a high-affinity iron chelator, as a treatment for neurodegenerative and neurovascular disease wi...
Kaydedildi:
| Yayımlandı: | Pharmaceuticals (Basel) |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7911954/ https://ncbi.nlm.nih.gov/pubmed/33513737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14020095 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|